Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situations.
Molimard M, Bernaud C, Lechat P; participants of round table n6 of Giens XXIX: Bejan-Angoulvant Theodora 4 Benattia Cherif 5 Benkritly Amel 6; Bejan-Angoulvant T, Benattia C, Benkritly A, Braunstein D, Cabut S, David N, Fourrier-Réglat A, Gallet B, Gersberg M, Goni S, Jolliet P, Lamarque-Garnier V, Le Jeunne C, Leurs I, Liard F, Malbezin M, Micallef J, Nguon M. Molimard M, et al. Therapie. 2014 Jul-Aug;69(4):355-66. doi: 10.2515/therapie/2014045. Epub 2014 Aug 8. Therapie. 2014. PMID: 25099666 English, French.
Information et communication sur les risques liés au médicament et son bon usage auprès des professionnels de santé et du public : principe de précaution, gestion du risque, communication pendant et en dehors des situations de crise.
Molimard M, Bernaud C, Lechat P; et les participants à la table ronde N°6 de Giens XXIX :; Bejan-Angoulvant T, Benattia C, Benkritly A, Braunstein D, Cabut S, David N, Fourrier-Réglat A, Gallet B, Gersberg M, Goni S, Jolliet P, Lamarque-Garnier V, Le Jeunne C, Leurs I, Liard F, Malbezin M, Micallef J, Nguon M. Molimard M, et al. Therapie. 2014 Jul-Aug;69(4):355-60. doi: 10.2515/therapie/2014044. Therapie. 2014. PMID: 27393228 French. No abstract available.
False positive results in preclinical research.
Angoulvant D, Bejan-Angoulvant T. Angoulvant D, et al. Therapie. 2017 Sep;72(4):411-413. doi: 10.1016/j.therap.2016.06.001. Epub 2016 Jun 22. Therapie. 2017. PMID: 27567552 No abstract available.
[Drugs news].
Bejan-Angoulvant T, Beau-Salinas F, Lengellé C, Cissoko H, Jonville-Béra AP. Bejan-Angoulvant T, et al. Arch Pediatr. 2014 Aug;21(8):897-901. doi: 10.1016/j.arcped.2014.05.008. Epub 2014 Jul 2. Arch Pediatr. 2014. PMID: 24997729 French. No abstract available.
The IDEAL study : towards personalized drug treatment of hypertension.
Bejan-Angoulvant T, Baguet JP, Erpeldinger S, Boivin JM, Mercier A, Leftheriotis G, Gagnol JP, Fauvel JP, Giraud C, Bricca G, Gueyffier F; IDEAL Study Group. Bejan-Angoulvant T, et al. Therapie. 2012 May-Jun;67(3):195-204. doi: 10.2515/therapie/2012031. Epub 2012 Aug 9. Therapie. 2012. PMID: 22874485 Clinical Trial.
[Update on beta blockers in 2020].
Bejan-Angoulvant T, Angoulvant D. Bejan-Angoulvant T, et al. Rev Med Interne. 2020 Nov;41(11):741-747. doi: 10.1016/j.revmed.2020.04.007. Epub 2020 Jun 10. Rev Med Interne. 2020. PMID: 32532560 Review. French.
98 results